Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| N2586 | Ruxolitinib | 0.3 | uM | 3 | IL-17 | 51.5 | 56 | ||||
| N2586 | Tofacitinib | 0.3 | uM | 3 | IL-17 | 48.0 | 85 | ||||
| N2586 | IKK16 | 2.0 | uM | 3 | IL-17 | 48.0 | 73 | ||||
| N2586 | 3 | IL-17 | 53.5 | 56 | |||||||
| RA2159 | Visfatin | 1 | ng/mL | 3 | IL-17 | 49.5 | 64 | ||||
| RA2159 | PD184352 | 0.1 | uM | Visfatin | 1 | ng/mL | 3 | IL-17 | 52.0 | 54 | |
| RA2159 | Lestaurtinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | IL-17 | 48.0 | 84 | |
| RA2159 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | IL-17 | 52.0 | 71 | |
| RA2159 | Tofacitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | IL-17 | 50.0 | 62 | |
| RA2159 | IKK16 | 2.0 | uM | Visfatin | 1 | ng/mL | 3 | IL-17 | 53.0 | 73 | |
| N2586 | Visfatin | 1 | ng/mL | 3 | IL-17 | 46.0 | 69 | ||||
| N2586 | PD184352 | 0.1 | uM | Visfatin | 1 | ng/mL | 3 | IL-17 | 50.5 | 74 | |
| N2586 | Lestaurtinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | IL-17 | 48.0 | 88 | |
| N2586 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | IL-17 | 47.0 | 53 | |
| N2586 | Tofacitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | IL-17 | 40.0 | 57 | |
| N2586 | IKK16 | 2.0 | uM | Visfatin | 1 | ng/mL | 3 | IL-17 | 43.0 | 64 | |
| RA2159 | Leptin | 1 | ng/mL | 3 | IL-17 | 51.0 | 74 | ||||
| RA2159 | PD184352 | 0.1 | uM | Leptin | 1 | ng/mL | 3 | IL-17 | 48.5 | 70 | |
| RA2159 | Lestaurtinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | IL-17 | 34.0 | 89 | |
| RA2159 | Ruxolitinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | IL-17 | 49.0 | 88 | |
| RA2159 | Tofacitinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | IL-17 | 42.0 | 60 | |
| RA2159 | IKK16 | 2.0 | uM | Leptin | 1 | ng/mL | 3 | IL-17 | 52.0 | 76 | |
| N2586 | Leptin | 1 | ng/mL | 3 | IL-17 | 43.5 | 86 | ||||
| N2586 | PD184352 | 0.1 | uM | Leptin | 1 | ng/mL | 3 | IL-17 | 49.0 | 71 | |
| N2586 | Lestaurtinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | IL-17 | 43.0 | 73 |